Krystal Biotech is trading at $357.52 (+6.66%) in pre-market, moving higher despite a lack of company-specific catalysts such as earnings, FDA news, or analyst updates.
- The move aligns with a broader risk-on sentiment across U.S. markets, as futures and major indexes rise following easing Middle East tensions and lower oil prices.
- Technical indicators for Krystal Biotech remain bullish, reflecting a steady upward trend even in the absence of fresh fundamental drivers.